Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pieter-Jan van Dam
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients
Cancer Treatment and Research Communications
Cancer Research
Oncology
Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer
Journal of Urology
Urology
Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Mechanisms of Acquired Resistance to Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Collateral Resistance to Taxanes in Enzalutamide-Resistant Prostate Cancer Through Aberrant Androgen Receptor and Its Variants
Cancer Science
Cancer Research
Medicine
Oncology
